|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
EP1280764B1
(en)
|
2000-03-24 |
2010-11-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
JPWO2002074298A1
(ja)
|
2001-03-21 |
2004-07-08 |
小野薬品工業株式会社 |
Ｉｌ−６産生阻害剤
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
DE60222921T2
(de)
|
2001-11-01 |
2008-08-07 |
Janssen Pharmaceutica N.V. |
Amidderivate als inhibitoren der glycogensynthasekinase-3-beta
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
JP2006520796A
(ja)
|
2003-03-17 |
2006-09-14 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼインヒビター
|
|
EP1644323B1
(en)
|
2003-07-07 |
2015-03-18 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
CA2561617A1
(en)
|
2004-04-05 |
2005-10-20 |
Aton Pharma, Inc. |
Histone deacetylase inhibitor prodrugs
|
|
US8999289B2
(en)
|
2005-03-22 |
2015-04-07 |
President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
|
JP2009509923A
(ja)
|
2005-08-26 |
2009-03-12 |
メシルジーン、インコーポレイテッド |
ヒストンデアセチラーゼのベンゾジアゼピン及びベンゾピペラジン類似体阻害薬
|
|
US8222423B2
(en)
|
2006-02-14 |
2012-07-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
CA2654540C
(en)
|
2006-05-03 |
2017-01-17 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
WO2007144341A1
(en)
|
2006-06-12 |
2007-12-21 |
Vrije Universiteit Brussel |
Differentiation of rat liver epithelial cells into hepatocyte-like cells
|
|
ES2288802B1
(es)
|
2006-07-07 |
2008-12-16 |
Universidad De Granada |
Nuevos derivados de ftalimida como inhibidores de las histonas desacetilasas.
|
|
CN101534831B
(zh)
|
2006-09-11 |
2013-07-17 |
柯瑞斯公司 |
包含锌结合基团的取代的酪氨酸抑制剂
|
|
CN101951930A
(zh)
|
2008-02-19 |
2011-01-19 |
阿奈斯特药品株式会社 |
对身体功能的恢复有用的口服或经肠组合物
|
|
CA2731730C
(en)
|
2008-07-23 |
2017-06-13 |
President And Fellows Of Harvard College |
Deacetylase inhibitors and uses thereof
|
|
EP2429987A4
(en)
|
2009-05-15 |
2012-10-03 |
Korea Res Inst Chem Tech |
AMIDE COMPOUND, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
|
|
US8716344B2
(en)
|
2009-08-11 |
2014-05-06 |
President And Fellows Of Harvard College |
Class- and isoform-specific HDAC inhibitors and uses thereof
|
|
MA33926B1
(fr)
*
|
2009-12-17 |
2013-01-02 |
Merck Sharp & Dohme |
Aminopyrimidines en tant qu'inhibiteurs de la syk
|
|
EP2638009A4
(en)
|
2010-01-08 |
2014-06-11 |
Harvard College |
FLUORINATED HDAC HEMMER AND USES THEREOF
|
|
RS55227B1
(sr)
|
2010-01-22 |
2017-02-28 |
Acetylon Pharmaceuticals Inc |
Jedinjenja reverznog amida kao inhibitori protein deacetilaze i postupci za njihovu upotrebu
|
|
WO2011146855A1
(en)
|
2010-05-21 |
2011-11-24 |
The Trustees Of Columbia University In The City Of New York |
Selective hdac inhibitors
|
|
WO2012018499A2
(en)
|
2010-08-05 |
2012-02-09 |
Acetylon Pharmaceuticals |
Specific regulation of cytokine levels by hdac6 inhibitors
|
|
CN107011270A
(zh)
|
2010-11-16 |
2017-08-04 |
阿塞蒂隆制药公司 |
作为蛋白质去乙酰化酶抑制剂的嘧啶羟基酰胺化合物和其使用方法
|
|
JP6169076B2
(ja)
|
2011-07-20 |
2017-07-26 |
ザ ジェネラル ホスピタル コーポレイション |
骨疾患の処置のためのヒストン脱アセチル化酵素６選択的阻害剤
|
|
US8841301B2
(en)
|
2011-09-26 |
2014-09-23 |
Bristol-Myers Squibb Company |
Selective NR2B antagonists
|
|
JP5724851B2
(ja)
*
|
2011-11-30 |
2015-05-27 |
東レ株式会社 |
Ｎ−（ヨードフェニル）ピリミジニルアミン誘導体の製造方法
|
|
US9663825B2
(en)
|
2012-04-19 |
2017-05-30 |
Acetylon Pharmaceuticals, Inc. |
Biomarkers to identify patients that will respond to treatment and treating such patients
|
|
WO2014059306A1
(en)
|
2012-10-12 |
2014-04-17 |
The Trustees Of The University Of Pennsylvania |
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
|
|
US9145412B2
(en)
|
2012-11-02 |
2015-09-29 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC1 and HDAC2 inhibitors
|
|
JP2016511237A
(ja)
|
2013-02-01 |
2016-04-14 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
選択的ｈｄａｃ３阻害剤
|
|
US9139583B2
(en)
|
2013-02-01 |
2015-09-22 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC3 inhibitors
|
|
US20140357512A1
(en)
|
2013-06-03 |
2014-12-04 |
Acetylon Pharmaceuticals, Inc. |
Histone deacetylase (hdac) biomarkers in multiple myeloma
|
|
EP3046559A4
(en)
|
2013-09-20 |
2017-03-22 |
Acetylon Pharmaceuticals, Inc. |
Treatment of diseases caused by abnormal lymphocyte function with an hdac6 inhibitor
|
|
WO2015054099A1
(en)
|
2013-10-08 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
Combinations of histone deacetylase inhibitors and either her2 inhibitors or pi3k inhibitors
|
|
US9278963B2
(en)
|
2013-10-10 |
2016-03-08 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
|
|
US20150105383A1
(en)
|
2013-10-10 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
HDAC Inhibitors, Alone Or In Combination With PI3K Inhibitors, For Treating Non-Hodgkin's Lymphoma
|
|
JP2016536354A
(ja)
|
2013-10-10 |
2016-11-24 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
非ホジキンリンパ腫を治療するための、ｈｄａｃ阻害剤単独またはｂｔｋ阻害剤との組み合わせ
|
|
PE20161342A1
(es)
|
2013-10-11 |
2016-12-31 |
Acetylon Pharmaceuticals Inc |
Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores
|
|
ES2918673T3
(es)
|
2013-10-24 |
2022-07-19 |
Mayo Found Medical Education & Res |
Tratamiento de enfermedades poliquísticas con un inhibidor de HDAC6
|
|
PE20161030A1
(es)
|
2013-12-03 |
2016-11-06 |
Acetylon Pharmaceuticals Inc |
Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
|
|
US20150176076A1
(en)
|
2013-12-20 |
2015-06-25 |
Acetylon Pharmaceuticals, Inc. |
Histone deacetylase 6 (hdac6) biomarkers in multiple myeloma
|
|
US9464073B2
(en)
|
2014-02-26 |
2016-10-11 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
|
|
US20150359794A1
(en)
|
2014-06-13 |
2015-12-17 |
Buck Institute For Research On Aging |
Impairment of the large ribosomal subunit protein rpl24 by depletion or acetylation
|
|
AU2015288060A1
(en)
|
2014-07-07 |
2017-02-09 |
Acetylon Pharmaceuticals, Inc. |
Treatment of leukemia with histone deacetylase inhibitors
|
|
CA2963681A1
(en)
|
2014-10-08 |
2016-04-14 |
Acetylon Pharmaceuticals, Inc. |
Induction of gata2 by hdac1 and hdac2 inhibitors
|
|
WO2016090230A1
(en)
|
2014-12-05 |
2016-06-09 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds for treating peripheral neuropathy
|
|
CA2969790A1
(en)
|
2014-12-05 |
2016-06-09 |
University of Modena and Reggio Emilia |
Combinations of histone deacetylase inhibitors and bendamustine
|
|
HK1251566A1
(zh)
|
2014-12-12 |
2019-02-01 |
Regenacy Pharmaceuticals, Llc |
作为hdac1/2抑制剂的呱啶衍生物
|
|
US20160339022A1
(en)
|
2015-04-17 |
2016-11-24 |
Acetylon Pharmaceuticals Inc. |
Treatment of neuroblastoma with histone deacetylase inhibitors
|
|
US10272084B2
(en)
|
2015-06-01 |
2019-04-30 |
Regenacy Pharmaceuticals, Llc |
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
|
|
US10144714B2
(en)
|
2015-06-08 |
2018-12-04 |
Acetylon Pharmaceuticals, Inc. |
Methods of making protein deacetylase inhibitors
|
|
TW201718516A
(zh)
|
2015-06-08 |
2017-06-01 |
艾斯特隆製藥公司 |
組蛋白去乙醯酶抑制劑之晶形
|
|
US11324744B2
(en)
|
2016-08-08 |
2022-05-10 |
Acetylon Pharmaceuticals Inc. |
Methods of use and pharmaceutical combinations of histone deacetylase inhibitors and CD20 inhibitory antibodies
|